Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice
暂无分享，去创建一个
S. Nakamoto | R. Muroyama | R. Nakagawa | T. Chiba | Naoya Kanogawa | S. Ogasawara | J. Kato | Soichiro Kiyono | T. Kondo | T. Taida | R. Azemoto | H. Mizumoto | K. Ito | Masato Nakamura | Yuki Haga | M. Atsukawa | N. Itokawa | T. Okubo | E. Itobayashi | Yotaro Iino | Kazufumi Kobayashi | S. Yumita | N. Kato | Keita Ogawa | M. Shinozaki | Hiroaki Kanzaki | Takamasa Ishino | Miyuki Nakagawa | K. Fujiwara | Terunao Iwanaga | T. Sakuma | K. Koroki | N. Fujita | R. Kojima | Masamichi Obu | Susumu Maruta | Tadayoshi Kogure | Yoshihiro Koma | Masanori Inoue | Atsuyoshi Seki | Y. Kikuchi | Naoya Kato | Shingo Nakamoto